Johnson Financial Group Inc. lifted its stake in Novanta Inc. (NASDAQ:NOVT – Free Report) by 482.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 326 shares of the technology company’s stock after acquiring an additional 270 shares during the quarter. Johnson Financial Group Inc.’s holdings in Novanta were worth $49,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds have also modified their holdings of the company. Norges Bank bought a new stake in Novanta in the fourth quarter worth $48,442,000. T. Rowe Price Investment Management Inc. boosted its holdings in Novanta by 69.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 680,169 shares of the technology company’s stock worth $103,910,000 after purchasing an additional 279,793 shares in the last quarter. WCM Investment Management LLC bought a new stake in Novanta in the fourth quarter worth $15,104,000. Schroder Investment Management Group boosted its holdings in Novanta by 52.5% in the fourth quarter. Schroder Investment Management Group now owns 271,583 shares of the technology company’s stock worth $41,359,000 after purchasing an additional 93,511 shares in the last quarter. Finally, Franklin Resources Inc. boosted its holdings in Novanta by 61.6% in the third quarter. Franklin Resources Inc. now owns 214,893 shares of the technology company’s stock worth $37,916,000 after purchasing an additional 81,942 shares in the last quarter. 98.35% of the stock is owned by institutional investors and hedge funds.
Novanta Stock Down 1.0 %
NOVT stock opened at $118.55 on Tuesday. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81. Novanta Inc. has a 52-week low of $98.76 and a 52-week high of $187.12. The company has a 50-day moving average of $127.90 and a two-hundred day moving average of $149.13. The stock has a market capitalization of $4.26 billion, a price-to-earnings ratio of 70.99 and a beta of 1.42.
Analyst Ratings Changes
Separately, Robert W. Baird decreased their price objective on shares of Novanta from $169.00 to $160.00 and set a “neutral” rating for the company in a report on Monday, March 3rd.
View Our Latest Stock Analysis on Novanta
Novanta Company Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Recommended Stories
- Five stocks we like better than Novanta
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Best Defense Stocks in 2025… So Far
- How to Choose Top Rated Stocks
- Alphabet Rebounds After Strong Earnings and Buyback Announcement
- What Investors Need to Know About Upcoming IPOs
- Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.